{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:39:04Z","timestamp":1779154744672,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bcp.2018.07.028","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T23:49:05Z","timestamp":1532216945000},"page":"479-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson\u2019s disease symptoms"],"prefix":"10.1016","volume":"155","author":[{"given":"Akanksha","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit Pratap","family":"Chandravanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra Kumar","family":"Trigun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sairam","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2018.07.028_b0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.028_b0015","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nn.4287","article-title":"Reward and choice encoding in terminals of midbrain dopamine neurons depends on striatal target","volume":"19","author":"Parker","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.028_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2016.10.008","article-title":"The threshold theory for Parkinson's disease","volume":"40","author":"Engelender","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bcp.2018.07.028_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bcp.2018.07.028_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","article-title":"Glucocerebrosidase and Parkinson disease: recent advances","volume":"66","author":"Schapira","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"issue":"17","key":"10.1016\/j.bcp.2018.07.028_b0050","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.bcp.2018.07.028_b0060","doi-asserted-by":"crossref","first-page":"14319","DOI":"10.1016\/S0021-9258(17)38720-3","article-title":"Biosynthesis of the lysosomal enzyme glucocerebrosidase","volume":"260","author":"Erickson","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0065","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of \u03b2-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"issue":"9645","key":"10.1016\/j.bcp.2018.07.028_b0070","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0075","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/ijms18040888","article-title":"Induced pluripotent stem cell modeling of Gaucher\u2019s disease: what have we learned?","volume":"18","author":"Santos","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.028_b0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","article-title":"Mitochondria and quality control defects in a mouse model of Gaucher disease\u2014links to Parkinson\u2019s disease","volume":"17","author":"Osellame","year":"2013","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.028_b0085","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"issue":"R1","key":"10.1016\/j.bcp.2018.07.028_b0090","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.bcp.2018.07.028_b0095","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/mds.21399","article-title":"Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease","volume":"22","author":"Chiara","year":"2007","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.177","article-title":"Progressive decline of glucocerebrosidase in aging and Parkinson's disease","volume":"2","author":"Rocha","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"342","key":"10.1016\/j.bcp.2018.07.028_b0105","doi-asserted-by":"crossref","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"S1","key":"10.1016\/j.bcp.2018.07.028_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","volume":"139","author":"Migdalska-Richards","year":"2016","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bcp.2018.07.028_b0115","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1007\/s11064-016-2011-0","article-title":"Neuroprotective effects of paeoniflorin on 6-OHDA-lesioned rat model of Parkinson\u2019s disease","volume":"41","author":"Gu","year":"2016","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0120","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Brit. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00441-017-2704-y","article-title":"Molecular mechanisms of \u03b1-synuclein and GBA1 in Parkinson\u2019s disease","volume":"373","author":"Stojkovska","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2018.07.028_b0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbi.2017.06.017","article-title":"Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases","volume":"65","author":"Girolamo","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bcp.2018.07.028_b0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","article-title":"Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant","volume":"46","author":"Bendikov-Bar","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"issue":"9","key":"10.1016\/j.bcp.2018.07.028_b0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11910-017-0778-2","article-title":"New therapeutic strategies for Lewy body dementias","volume":"17","author":"Velayudhan","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2018.07.028_b0150","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.24790","article-title":"Ambroxol effects in glucocerebrosidase and \u03b1-synuclein transgenic mice","volume":"80","author":"Migdalska-Richards","year":"2016","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.bcp.2018.07.028_b0155","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2018.07.028_b0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nbd.2015.06.008","article-title":"Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells","volume":"82","author":"Ambrosi","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"13","key":"10.1016\/j.bcp.2018.07.028_b0165","first-page":"2712","article-title":"The contribution of mutant GBA to the development of Parkinson disease in Drosophila","volume":"25","author":"Maor","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2018.07.028_b0170","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12640-017-9712-2","article-title":"Complex changes in the innate and adaptive immunity accompany progressive degeneration of the nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine in the rat","volume":"32","author":"Ambrosi","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bcp.2018.07.028_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","article-title":"Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms","volume":"1471","author":"Kumar","year":"2012","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0185","first-page":"1","article-title":"Neuroprotective and anti-nociceptive potential of ambroxol in oxaliplatin induced peripheral neuropathic pain in rats","volume":"8","author":"Bhardwaj","year":"2016","journal-title":"Biol. Med."},{"issue":"8","key":"10.1016\/j.bcp.2018.07.028_b0190","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","article-title":"Ambroxol in the 21st century: pharmacological and clinical update","volume":"4","author":"Malerba","year":"2008","journal-title":"Expert Opi. Drug met. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bcmd.2013.03.006","article-title":"Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease","volume":"51","author":"Sanders","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pbb.2010.08.006","article-title":"Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain","volume":"97","author":"Hama","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3892\/ijmm.2013.1450","article-title":"Selegiline rescues gait deficits and the loss of dopaminergic neurons in a subacute MPTP mouse model of Parkinson's disease","volume":"32","author":"Zhao","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2018.07.028_b0215","doi-asserted-by":"crossref","first-page":"e78220","DOI":"10.1371\/journal.pone.0078220","article-title":"Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson\u2019s disease","volume":"8","author":"Zhao","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.bcp.2018.07.028_b0220","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1007\/s12035-016-0084-z","article-title":"Antioxidant-rich fraction of Urtica dioica mediated rescue of striatal mito-oxidative damage in MPTP-induced behavioral, cellular, and neurochemical alterations in rats","volume":"54","author":"Bisht","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0225","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s12031-017-0891-3","article-title":"Neuroprotective effects and mechanisms of action of multifunctional agents targeting free radicals, monoamine oxidase B and cholinesterase in Parkinson\u2019s disease model","volume":"61","author":"Liu","year":"2017","journal-title":"J. Mol. Neurosci."},{"issue":"S367","key":"10.1016\/j.bcp.2018.07.028_b0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"82","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1037\/h0032986","article-title":"Open-field behavior of the rat as a function of age: cross-sectional and longitudinal investigations","volume":"80","author":"Bronstein","year":"1972","journal-title":"J. Comp. Physiol. Psychol."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1385-299X(97)00034-2","article-title":"An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism","volume":"2","author":"Rozas","year":"1997","journal-title":"Brain Res. Protoc."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.028_b0245","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1073\/pnas.95.3.1253","article-title":"Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia","volume":"95","author":"Fernandez","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.028_b0250","first-page":"233","article-title":"A method for the routine assessment of fore-and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2018.07.028_b0255","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.028_b0260","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pbb.2013.12.008","article-title":"Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats","volume":"117","author":"Geed","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bcp.2018.07.028_b0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0021-9673(01)94581-9","volume":"386","author":"Kim","year":"1987","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0270","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.028_b0275","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/ars.2015.6307","article-title":"Sustained systemic glucocerebrosidase inhibition induces brain \u03b1-synuclein aggregation, microglia and complement C1q activation in mice","volume":"23","author":"Rocha","year":"2015","journal-title":"Antioxidants Redox Signal."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.028_b0280","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria","volume":"73","author":"Berman","year":"1999","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0285","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","article-title":"Mechanism of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction","volume":"69","author":"Liu","year":"1997","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0290","first-page":"227","article-title":"Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model","volume":"13","author":"Sedaghat","year":"2014","journal-title":"Iran. J. Pharmac. Res.: IJPR"},{"issue":"5","key":"10.1016\/j.bcp.2018.07.028_b0295","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1745-7254.2008.00787.x","article-title":"Bilobalide inhibits 6-OHDA-induced activation of NF-\u03baB and loss of dopaminergic neurons in rat substantia nigra","volume":"29","author":"Li","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2018.07.028_b0300","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","article-title":"Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration","volume":"12","author":"Hambright","year":"2017","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0305","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","article-title":"\u201cWestern blotting\u201d: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A","volume":"112","author":"Burnette","year":"1981","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000339456","article-title":"Motor Symptoms and Schizophrenia","volume":"66","author":"Walther","year":"2012","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0166-4328(90)90005-Y","article-title":"Red nucleus lesions do not affect limb preference or use, but exacerbate the effects of motor cortex lesions on grasping in the rat","volume":"40","author":"Whishaw","year":"1990","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0091-3057(86)90037-7","article-title":"Central 6-OHDA affects both open-field exploratory behaviour and the development of hypertension in SHR","volume":"24","author":"Van Den Buuse","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/dev.21586","article-title":"Prenatal exposure to ketamine in rats: implications on animal models of schizophrenia","volume":"60","author":"Coronel-Oliveros","year":"2018","journal-title":"Dev. Psychobiol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2018.07.028_b0330","first-page":"111","article-title":"Rearing on hind legs, environmental novelty, and the hippocampal formation","volume":"17","author":"Lever","year":"2006","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.028_b0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-60761-303-9_2","article-title":"Analysis of grooming behavior and its utility in studying animal stress, anxiety, and depression","author":"Smolinsky","year":"2009","journal-title":"Mood Anxiety Related Phenotypes Mice"},{"key":"10.1016\/j.bcp.2018.07.028_b0340","doi-asserted-by":"crossref","first-page":"42323","DOI":"10.1038\/srep42323","article-title":"Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice","volume":"7","author":"Takeshita","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0345","first-page":"317","article-title":"Increase of oxidative stress and accumulation of \u03b1-synuclein in Wistar Rat's Midbrain treated with rotenone","volume":"44A","author":"Budi","year":"2012","journal-title":"ITB J."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0350","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0361-9230(91)90242-C","article-title":"Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats","volume":"26","author":"Berger","year":"1991","journal-title":"Brain Res. Bull."},{"issue":"12","key":"10.1016\/j.bcp.2018.07.028_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-017-2383-9","article-title":"Purinergic antagonism prevents mitochondrial dysfunction and behavioral deficits associated with dopaminergic toxicity induced by 6-OHDA in rats","volume":"42","author":"Kumar","year":"2017","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/S0100-879X2003000200011","article-title":"Effects of septal cholinergic lesion on rat exploratory behavior in an open-field","volume":"36","author":"Lamprea","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0365","first-page":"411","article-title":"Serotonin1A receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats","volume":"21","author":"Batool","year":"2008","journal-title":"Pakistan j. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0370","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2013.12.003","article-title":"Neuroinflammation and \u03b1-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction","volume":"111","author":"Ginns","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2018.07.028_b0375","series-title":"Chapter 8 \u2013 Axonal Transport, Basic Neurochemistry","first-page":"146","author":"Morfini","year":"2012"},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0380","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuron.2014.10.019","article-title":"Axonal transport: cargo-specific mechanisms of motility and regulation","volume":"84","author":"Maday","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1460-9568.2006.05285.x","article-title":"Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model","volume":"25","author":"Blandini","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2018.07.028_b0390","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nbd.2015.09.009","article-title":"Glucocerebrosidase gene therapy prevents \u03b1-synucleinopathy of midbrain dopamine neurons","volume":"82","author":"Rocha","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"35","key":"10.1016\/j.bcp.2018.07.028_b0395","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.07.028_b0400","doi-asserted-by":"crossref","first-page":"31380","DOI":"10.1038\/srep31380","article-title":"Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models","volume":"6","author":"Sanchez-Martinez","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.028_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.028_b0410","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson\u2019s disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Movement Disorders: Off. J. Movement Disorder Soc."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.028_b0415","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajmg.b.32549","article-title":"Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: review and meta-analyses","volume":"177","author":"Creese","year":"2017","journal-title":"Am. J. Med. Genetics Part B: Neuropsychiatric Genetics"},{"issue":"32","key":"10.1016\/j.bcp.2018.07.028_b0420","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"\u03b1-Synuclein interacts with glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"Yap","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.028_b0425","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12640-016-9693-6","article-title":"Coenzyme Q10 prevents mitochondrial dysfunction and facilitates pharmacological activity of atorvastatin in 6-OHDA induced dopaminergic toxicity in rats","volume":"31","author":"Prajapati","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bcp.2018.07.028_b0430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2009.06.060","article-title":"Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease","volume":"1286","author":"Cheng","year":"2009","journal-title":"Brain Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521830296X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521830296X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T01:19:30Z","timestamp":1661649570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521830296X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":86,"alternative-id":["S000629521830296X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.028","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson\u2019s disease symptoms","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}